David Slack
Amministratore Delegato presso Cend Therapeutics, Inc.
Patrimonio netto: 7 767 $ in data 31/05/2024
Posizioni attive di David Slack
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cend Therapeutics, Inc.
 Cend Therapeutics, Inc. BiotechnologyHealth Technology Cend Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapies for solid tumor cancers. Its offers CendR Platform, which provides a targeted tissue penetration capability to specifically enhance drug delivery to tumors. Its lead compound CEND-1 seeks out tumors and activates the CendR transport pathway. The company was founded by Erkki Ruoslahti in 2016 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/10/2019 | - |
| Amministratore Delegato | 08/07/2020 | - | |
| Presidente | 08/07/2020 | - | |
| Lisata Therapeutics Australia Pty Ltd. | Presidente | - | - |
Storia della carriera di David Slack
Precedenti posizioni note di David Slack
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LISATA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 15/09/2022 | 01/05/2023 |
| Presidente | 15/09/2022 | 01/05/2023 | |
| DS Lifescience Consulting | Corporate Officer/Principal | 01/01/2004 | 01/03/2021 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Corporate Officer/Principal | 01/08/2016 | 01/07/2020 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2004 |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
Formazione di David Slack
| California State University-Sacramento | Undergraduate Degree |
| Monterey Institute of International Studies | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
| Australia | 2 |
Posizioni
| Corporate Officer/Principal | 5 |
| Director/Board Member | 2 |
| President | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LISATA THERAPEUTICS, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Cend Therapeutics, Inc.
Cend Therapeutics, Inc. BiotechnologyHealth Technology Cend Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapies for solid tumor cancers. Its offers CendR Platform, which provides a targeted tissue penetration capability to specifically enhance drug delivery to tumors. Its lead compound CEND-1 seeks out tumors and activates the CendR transport pathway. The company was founded by Erkki Ruoslahti in 2016 and is headquartered in San Diego, CA. | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
| Lisata Therapeutics Australia Pty Ltd. | |
| DS Lifescience Consulting | |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
- Borsa valori
- Insiders
- David Slack
- Esperienza
